Skip to main content

From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 23 December

Jessica Amir
December 23, 2020

Morning Bell 22 December

Jessica Amir
December 22, 2020

Morning Bell 21 December

Jessica Amir
December 21, 2020

Weekly Wrap 18 December

Jessica Amir
December 18, 2020

Morning Bell 18 December

Jessica Amir
December 18, 2020

Morning Bell 17 December

Jessica Amir
December 17, 2020

Morning Bell 16 December

Jessica Amir
December 16, 2020

Morning Bell 15 December

Jessica Amir
December 15, 2020

Morning Bell 14 December

Jessica Amir
December 14, 2020

Weekly Wrap 11 December

Jessica Amir
December 11, 2020